Patents by Inventor Sagar Beldar

Sagar Beldar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
    Patent number: 11708337
    Abstract: This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: July 25, 2023
    Assignee: G1 Therapeutics, Inc.
    Inventors: Stephen E. Schneider, Hannah White, Thomas Fessard, Sagar Beldar
  • SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE
    Publication number: 20210179567
    Abstract: This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.
    Type: Application
    Filed: February 24, 2021
    Publication date: June 17, 2021
    Applicant: G1 Therapeutics, Inc.
    Inventors: Stephen E. Schneider, Hannah White, Thomas Fessard, Sagar Beldar